LigaChem Biosciences Inc. (KOSDAQ:141080)

LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 5.53B KRW in the quarter ending June 30, 2026, a decrease of -83.04%. This brings the company's total for the last twelve months to 98.78B, down -33.38% year-over-year. In the year 2025, LigaChem Biosciences had annual revenue of 141.55B with 12.43% growth. That makes LigaChem Biosciences the 24,912th largest company in the world by revenue and 1,453rd in South Korea.

• Revenue (ttm): 98.78B
• Revenue Growth: -33.38%
• P/S Ratio: 25.44
• Revenue / Employee: 539.79M
• Employees: 183
• Market Cap: 2.51T

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• New Drug Research and Development 121.16B 85.6%
• Pharmaceutical Business 20.39B 14.4%

Fiscal year ended Dec 31, 2025 See the full LigaChem Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.55B	15.65B	12.43%
Dec 31, 2024	125.90B	91.75B	268.71%
Dec 31, 2023	34.15B	733.60M	2.20%
Dec 31, 2022	33.41B	1.26B	3.90%
Dec 31, 2021	32.16B	-25.34B	-44.07%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error